SNHG15 has been linked to lower survival in a lot of human malignancies, including breast cancer, colorectal cancer, gastric cancer, glioma, hepatocellular cancer, lung cancer, osteosarcoma, ovarian cancer, pancreatic cancer, renal cell carcinoma and thyroid cancer [25,26]. This evidence concerns the gene SNHG15 and hepatocellular carcinoma.